Senores Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 45.81% of Senores Pharmaceuticals, FIIs hold 6.01%, DIIs hold 10.85% and the public holds 37.32%. Promoter holding fell by 0.01 percentage points from Jun 2026.
Get an alert when Senores Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
45.81%
−0.01 pp QoQ
FIIs
6.01%
−0.61 pp QoQ
DIIs
10.85%
+1.08 pp QoQ
Public
37.32%
−0.46 pp QoQ
Senores Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 45.81% | 6.01% | 10.85% | 37.32% | 42,642 |
| Jun 2026 | 45.82% | 6.62% | 9.77% | 37.78% | 36,498 |
| Mar 2026 | 45.82% | 3.64% | 9.62% | 40.92% | 34,126 |
| Dec 2025 | 45.81% | 3.35% | 9.32% | 41.54% | 34,401 |
| Sep 2025 | 45.80% | 4.28% | 8.62% | 41.30% | 34,917 |
| Jun 2025 | 45.78% | 3.66% | 9.51% | 41.03% | 36,389 |
| Mar 2025 | 45.78% | 4.17% | 9.66% | 40.39% | 37,653 |
| Dec 2024 | 45.77% | 4.25% | 11.77% | 38.20% | 49,518 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹5.42k cr, the promoter group's 45.81% stake is worth ₹2.48k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Senores Pharmaceuticals shareholding: common questions
What is the promoter holding in Senores Pharmaceuticals?
Promoters hold 45.81% of Senores Pharmaceuticals as of Sep 2026. Their stake fell by 0.01 percentage points from Jun 2026.
How much do FIIs hold in Senores Pharmaceuticals?
Foreign institutional investors (FIIs) held 6.01% of Senores Pharmaceuticals in Sep 2026, −0.61 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Senores Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 10.85% of Senores Pharmaceuticals in Sep 2026, +1.08 pp versus Jun 2026.
Is the promoter holding in Senores Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Senores Pharmaceuticals.
How has Senores Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 45.80% in Sep 2025 to 45.81% in Sep 2026 (+0.01 pp).
How many shareholders does Senores Pharmaceuticals have?
Senores Pharmaceuticals had 42,642 shareholders in Sep 2026, compared with 36,498 in Jun 2026.